New Indian Regulatory Guidance by Central Drugs Standard Control Organization Guidance for Industry on Submission of Clinical Trial Application for Evaluating Safety and Efficacy - Central Drugs Standard Control Organization...

Indian Clinical Data Management market is expected to ramp up to $150 million MNCs are more than willing to outsource their needs to India because of it\'s technological innovation, creditable quality, operational flexibility, cost effectiveness, time-to-market and competitive advantage according to Koteshwar Govind, Deputy Manager,...

India: Attractive Market for Biopharmaceutical Companies Looking to Accelerate Their Clinical Trials The Clinical Research Market in India is growing at a very rapid rate according to anyone’s statistics…It is exploding according to all the hype. ...

more...

Site Management » Ethics Committee Submission & Approval

Prior to study initiation, Neeman coordinator initiates contact with Institutional ethics committee of the site selected for the study.

The regulatory department understands the individual SOPs of the institutional EC to get approval in the shortest possible time

www.maxindia.com

Disclaimer | Privacy Policy